Jackson Creek Investment Advisors LLC Sells 15,486 Shares of Encompass Health Corporation $EHC

Jackson Creek Investment Advisors LLC lessened its holdings in shares of Encompass Health Corporation (NYSE:EHC) by 76.9% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 4,650 shares of the company’s stock after selling 15,486 shares during the period. Jackson Creek Investment Advisors LLC’s holdings in Encompass Health were worth $494,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Westside Investment Management Inc. grew its holdings in shares of Encompass Health by 56.7% during the third quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock worth $35,000 after purchasing an additional 101 shares during the last quarter. Assetmark Inc. grew its holdings in shares of Encompass Health by 88.1% during the third quarter. Assetmark Inc. now owns 299 shares of the company’s stock worth $38,000 after purchasing an additional 140 shares during the last quarter. WPG Advisers LLC boosted its holdings in Encompass Health by 73.3% in the fourth quarter. WPG Advisers LLC now owns 324 shares of the company’s stock valued at $34,000 after acquiring an additional 137 shares during the last quarter. Flagship Harbor Advisors LLC bought a new position in Encompass Health in the fourth quarter valued at about $37,000. Finally, Caitong International Asset Management Co. Ltd boosted its holdings in Encompass Health by 36,200.0% in the third quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock valued at $46,000 after acquiring an additional 362 shares during the last quarter. Institutional investors own 97.25% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on EHC. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Barclays decreased their price target on Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a report on Tuesday, May 5th. Finally, Leerink Partners set a $152.00 price target on Encompass Health in a report on Friday, May 22nd. Two analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, Encompass Health presently has an average rating of “Buy” and a consensus price target of $145.29.

Encompass Health Trading Down 0.5%

NYSE:EHC opened at $104.40 on Thursday. Encompass Health Corporation has a 1-year low of $92.77 and a 1-year high of $127.99. The business’s 50-day moving average price is $103.10 and its two-hundred day moving average price is $105.50. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.76. The firm has a market capitalization of $10.36 billion, a price-to-earnings ratio of 17.43, a PEG ratio of 2.29 and a beta of 0.72.

Encompass Health (NYSE:EHC) last released its earnings results on Thursday, April 30th. The company reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.51 by $0.09. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The firm had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.57 billion. During the same quarter in the prior year, the firm posted $1.37 earnings per share. The company’s quarterly revenue was up 9.0% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. On average, equities analysts expect that Encompass Health Corporation will post 5.96 earnings per share for the current year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be given a dividend of $0.19 per share. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is currently 12.69%.

Insider Transactions at Encompass Health

In other news, Treasurer Edmund Fay sold 11,937 shares of the firm’s stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $107.00, for a total transaction of $1,277,259.00. Following the sale, the treasurer owned 89,325 shares of the company’s stock, valued at $9,557,775. This trade represents a 11.79% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Patrick William Tuer sold 682 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $104.56, for a total value of $71,309.92. Following the sale, the executive vice president directly owned 24,755 shares in the company, valued at approximately $2,588,382.80. This represents a 2.68% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.80% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.